Industry Educational Session - Bridging evidence and practice: Real world management strategies for treating patients with newly diagnosed AML who are ineligible for intensive chemotherapy. AbbVie Promotional Symposium - Sponsored by Abbvie
Tracks
-
| Monday, April 28, 2025 |
| 11:15 AM - 11:45 AM |
| M2 & M3 |
Details
This AbbVie promotional symposium for UK healthcare professionals will review a large UK NHS real-world cohort of over 650 newly diagnosed adult AML patients who are ineligible for intensive chemotherapy. This includes real-world data, expert insights, patient case studies and a live Q&A.
AbbVie products will be discussed.
This promotional symposium is organised and funded by AbbVie UK and this content is intended for UK healthcare professionals only.
Prescribing information and adverse event reporting information will be available at the symposium.
UK-VNCAML-250006, March 2025
Speaker
Dr Pramila Krishnamurthy
Consultant Haematologist
King's College Hospital NHS Foundation Trust
_ Consultant Haematologist and honorary senior lecturer at King’s College Hospital and King’s College London respectively.
Dr Sevillano Zamarreno
Haemato-oncology Consultant, specialist
- Haemato-oncology Consultant, specialist interest in the acute leukaemias, bone marrow failure and stem cell transplant, St. George’s Hospital.
Dr. Jennifer Vidler
Haematology Spr
King's College Hospital NHS Foundation Trust
- Haematology Registrar and current Myeloid and Transplant Clinical Trials Fellow at King’s College Hospital, London. Her work focuses on the design and delivery of high-quality clinical trials in haematology
